SUPREME-HN A Retrospective Cohort Study of PD-L1 in Recurrent and Metastatic Squamous Cell Carcinoma of Head and Neck (SCCHN)

Trial Identifier: D4193R00002
Sponsor: AstraZeneca
NCTID:: NCT02543476
Start Date: September 2015
Primary Completion Date: November 2016
Study Completion Date: November 2016
Condition: Cancer - Other

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations